RARE - Ultragenyx Pharmaceutical GAAP EPS of -$2.19 misses by $0.41 revenue of $79.9M misses by $4.35M May, 05 2022 04:15 PM Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceutical press release (NASDAQ:RARE): Q1 GAAP EPS of -$2.19 misses by $0.41. Revenue of $79.9M (-19.6% Y/Y) misses by $4.35M. Shares -6.46%. For further details see: Ultragenyx Pharmaceutical GAAP EPS of -$2.19 misses by $0.41, revenue of $79.9M misses by $4.35M